The Implications of Liver Biopsy Results in Patients with Myeloproliferative Neoplasms Being Treated with Ruxolitinib

Ruxolitinib is increasingly being utilized for the treatment of myelofibrosis and polycythemia vera, but the potential for hepatic toxicity is poorly understood. We performed a retrospective review of hepatic damage occurring in patients with myeloproliferative neoplasms receiving ruxolitinib. Relev...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Case Rep Hematol
Main Authors: Tremblay, Douglas, Putra, Juan, Vogel, Alexander, Winters, Adam, Hoffman, Ronald, Schiano, Thomas D., Fiel, Maria Isabel, Mascarenhas, John O.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6339753/
https://ncbi.nlm.nih.gov/pubmed/30723558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3294046
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados